Yuqiong Huang
Overview
Explore the profile of Yuqiong Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tao Q, Liu S, Zhang J, Jiang J, Jin Z, Huang Y, et al.
iScience
. 2023 Aug;
26(9):107485.
PMID: 37636055
Smart wearable sensors are electronic devices worn on the body that collect, process, and transmit various physiological data. Compared to traditional devices, their advantages in terms of portability and comfort...
2.
Fu B, Jiang J, Huang Y
Exp Anim
. 2023 Jun;
72(4):496-504.
PMID: 37331802
Neuropathic pain (NP) is caused by diseases or dysfunction of nervous system and has a considerable negative impact on patients' quality of life. Opioid analgesics can be used for NP...
3.
Chen W, Huang Y, Cui H, Li S, Feng Y, Zhang B
Small Methods
. 2023 Jan;
7(3):e2201276.
PMID: 36717279
The power conversion efficiency (PCE) of tin-lead perovskite solar cells (PSCs) is normally lower than that of Pb cells, mainly due to greater open circuit voltage (V ) losses. Herein,...
4.
Kong Y, Jiang J, Huang Y, Liu X, Jin Z, Li L, et al.
Front Immunol
. 2023 Jan;
13:1094375.
PMID: 36700214
Introduction: Psoriasis is a common inflammatory skin disease recognized by the World Health Organization as "an incurable chronic, noninfectious, painful, disfiguring and disabling disease." The fact that metabolic syndrome (MetS)...
5.
Liu X, Li L, Jiang J, Ge W, Huang Y, Jin Z, et al.
J Invest Dermatol
. 2022 Nov;
143(5):812-821.e3.
PMID: 36410425
Type I cannabinoid receptor (CB1R) has been reported to exhibit favorable anti-inflammation and antipruritus effects against inflammation-based skin diseases, but the specific mechanism remains to be explored. In this study,...
6.
Kong Y, Jiang J, Huang Y, Li L, Liu X, Jin Z, et al.
Biomed Pharmacother
. 2022 Oct;
155:113741.
PMID: 36271543
Melanoma is the most lethal skin cancer with rising incidence worldwide. Despite significant advances in target therapy and immunotherapy, low response rates and the development of drug resistance remain key...
7.
Zuo Y, Dai L, Li L, Huang Y, Liu X, Liu X, et al.
Front Pharmacol
. 2022 Jul;
13:850967.
PMID: 35860030
: Psoriasis is characterized by keratinocyte proliferation and massive inflammatory leukocytes infiltration, affecting 0.14%-1.99% of the world's population. Our aim was to identify novel potential therapeutic strategies for psoriasis. :...
8.
Li L, Liu X, Ge W, Chen C, Huang Y, Jin Z, et al.
Front Pharmacol
. 2022 Feb;
13:790712.
PMID: 35173615
Cannabinoid receptor 2 (CB2R) is a potential target for anti-inflammatory and pain therapeutics given its significant immunomodulatory and analgesic effects. However, the role of CB2R in imiquimod (IMQ)-induced psoriasiform dermatitis...
9.
Su K, Zhao P, Ren Y, Zhang Y, Yang G, Huang Y, et al.
ACS Appl Mater Interfaces
. 2021 Mar;
13(12):14248-14257.
PMID: 33734692
Surface defects of perovskite films are the major sources of nonradiative recombination which limit the efficiency and stability of perovskite solar cells. Surface passivation represents one of the most efficient...
10.
Liu N, Liu Z, Liu X, Duan X, Huang Y, Jin Z, et al.
Front Genet
. 2020 Oct;
11:1002.
PMID: 33005180
Melanoma is the leading cause of cancer-related death among skin tumors, with an increasing incidence worldwide. Few studies have effectively investigated the significance of an immune-related gene (IRG) signature for...